ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,930.85
1.09%
Dow Jones
42,840.26
1.18%
US Dollar vs MXN
20.0813
0.00%
Brent Oil
72.72
0.00%
Bitcoin
95,475.14
-1.79%
Pepperstone
Advertisement
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. XOMA Royalty Corporation (XOMAO) Cotización

XOMA Royalty Corporation

XOMA Royalty Corporation (XOMAO)

NASDAQ
25.73
0.2181
(0.855063%)
Cerrado 22 Diciembre 3:00PM
Delayed by 15 minutes
25.73
0.00
(0.00%)
Fuera de horario: 3:07PM
Delayed by 15 minutes

Su centro para precios en tiempo real, ideas y debates en vivo

Premium

Estadísticas y detalles clave

Último Precio
25.73
Postura de Compra
25.12
Postura de Venta
26.13
Volume Operado de la Acción
1,378
25.51 Rango del Día 25.73
0.00 Rango de 52 semanas 0.00
Capitalización de Mercado [m]
303.111M
Precio Anterior
25.51
Precio de Apertura
25.55
Hora
27
@
25.64
Última hora de negociación
Volumen financiero
US$ 35,182
Precio Promedio Ponderado
25.53
Volumen promedio (3 m)
-
Acciones en circulación
11,782,723
Rendimiento del Dividendo
10.17%
Ratio Precio/Utilidad
-7.75
Beneficio por acción (BPA)
-3.47
turnover
4.76M
Beneficio neto
-40.83M

Acerca de XOMA Royalty Corporation

XOMA Corp is a biotechnology royalty aggregator playing a unique role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnolo... XOMA Corp is a biotechnology royalty aggregator playing a unique role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.xoma.com
Sede
Wilmington, Delaware, USA
Fundado
-
XOMA Royalty Corporation is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker XOMAO. The last closing price for XOMA Royalty was US$25.51. Over the last year, XOMA Royalty shares have traded in a share price range of US$ 0.00 to US$ 0.00.

XOMA Royalty currently has 11,782,723 shares in issue. The market capitalisation of XOMA Royalty is US$300.54 million. XOMA Royalty has a price to earnings ratio (PE ratio) of -7.75.

XOMAO Últimas noticias

Más noticias

XOMA Royalty Declares Quarterly Preferred Stock Dividends

EMERYVILLE, Calif., Dec. 19, 2024 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA) today announced its Board of Directors has authorized the following cash dividends to holders of...

19 Diciembre 2024
GlobeNewswire Inc.

XOMA Royalty Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in Seralutinib, a Phase 3 Asset, to Its Portfolio

Seralutinib becomes XOMA Royalty’s seventh Phase 3 royalty asset, further building the late-stage pipeline beyond its six current commercial royalty assets Seralutinib is being developed and...

02 Diciembre 2024
GlobeNewswire Inc.

XOMA Royalty Reports Third Quarter 2024 Financial Results and Highlights Recent Activities

Zevra’s MIPLYFFA™ (arimoclomol) received FDA approval and became the sixth commercial asset in XOMA Royalty’s portfolio XOMA Royalty acquired a 50 percent economic interest in TWIST Bioscience’s...

07 Noviembre 2024
GlobeNewswire Inc.

XOMA Royalty Significantly Expands its Royalty and Milestone Portfolio with the Addition of Over 60 Early-Stage Programs from Twist Bioscience

XOMA Royalty has acquired 50 percent of Twist’s existing royalty and milestone economics for $15 million XOMA Royalty’s portfolio now holds over 100 assets ranging from revenue-generating...

22 Octubre 2024
GlobeNewswire Inc.

Zevra’s MIPLYFFA™ (arimoclomol) Receives Approval from U.S. Food and Drug Administration for Use in Patients with Niemann-Pick Disease Type C (NPC)

MIPLYFFA™ is the first therapy approved for use in patients with NPC, a rare genetic disorder XOMA Royalty is entitled to receive a mid-single digit royalty on MIPLYFFA™ sales and up to $52.6...

23 Septiembre 2024
GlobeNewswire Inc.

XOMA Royalty Declares Quarterly Preferred Stock Dividends

 EMERYVILLE, Calif., Sept. 23, 2024 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors has authorized the following...

23 Septiembre 2024
GlobeNewswire Inc.

XOMA Royalty to Present at Upcoming Investor Conferences in September

EMERYVILLE, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today members of its Executive Team will participate at...

04 Septiembre 2024
GlobeNewswire Inc.

XOMA Royalty Reports Second Quarter 2024 Financial Results and Highlights Recent Activities

Cash receipts totaled $22.6 million in 2Q24, inclusive of royalty income and milestones from Day One Pharmaceuticals and Rezolute Expanded the commercial royalty and milestone portfolio with the...

13 Agosto 2024
GlobeNewswire Inc.

XOMA Declares Quarterly Preferred Stock Dividends

EMERYVILLE, Calif., June 20, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors has authorized the following cash dividends...

20 Junio 2024
GlobeNewswire Inc.

XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals’ Sale of its Priority Review Voucher

EMERYVILLE, Calif., June 12, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today it has received an $8.1 million milestone payment from...

12 Junio 2024
GlobeNewswire Inc.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000PR
40000000PR
120000000PR
260000000PR
520000000PR
1560000000PR
2600000000PR

XOMAO - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de XOMA Royalty?
El precio actual de las acciones de XOMA Royalty es US$ 25.73
¿Cuántas acciones de XOMA Royalty están en circulación?
XOMA Royalty tiene 11,782,723 acciones en circulación
¿Cuál es la capitalización de mercado de XOMA Royalty?
La capitalización de mercado de XOMA Royalty es USD 300.54M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de XOMA Royalty?
XOMA Royalty ha negociado en un rango de US$ 0.00 a US$ 0.00 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de XOMA Royalty?
El ratio precio/beneficio de XOMA Royalty es -7.75
¿Cuál es el ratio de efectivo a ventas de XOMA Royalty?
El ratio de efectivo a ventas de XOMA Royalty es 66.49
¿Cuál es la moneda de reporte de XOMA Royalty?
XOMA Royalty presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de XOMA Royalty?
El último ingresos anual de XOMA Royalty es USD 4.76M
¿Cuál es el último beneficio anual de XOMA Royalty?
El último beneficio anual de XOMA Royalty es USD -40.83M
¿Cuál es la dirección registrada de XOMA Royalty?
La dirección registrada de XOMA Royalty es CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
¿Cuál es la dirección del sitio web de XOMA Royalty?
La dirección del sitio web de XOMA Royalty es www.xoma.com
¿En qué sector industrial opera XOMA Royalty?
XOMA Royalty opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
MYSZMy Size Inc
US$ 4.2001
(211.12%)
121.03M
NVNINVNI Group Ltd
US$ 8.26
(209.36%)
78.06M
TPICTPI Composites Inc
US$ 2.45
(100.82%)
34M
ICGIntchains Group Ltd
US$ 8.77
(88.60%)
527.94k
HSDTHelius Medical Technologies Inc
US$ 0.884851
(84.34%)
121.95M
CYNCYNGN Inc
US$ 0.4603
(-71.41%)
27.91M
MTEMMolecular Templates Inc
US$ 0.1502
(-57.09%)
8.75M
PRFXPainReform Ltd
US$ 5.15
(-53.85%)
2.94M
GALTGalectin Therapeutics Inc
US$ 1.03
(-48.50%)
9.27M
BCABBioAtla Inc
US$ 0.6923
(-41.82%)
6.25M
EDBLEdible Garden AG Inc
US$ 0.24
(65.06%)
354.32M
APTOAptose Biosciences Inc
US$ 0.28
(64.51%)
305.1M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.606999
(6.49%)
292.16M
NVDANVIDIA Corporation
US$ 134.70
(3.08%)
287.21M
PLTRPalantir Technologies Inc
US$ 80.55
(8.54%)
277.63M

Discusión

Ver feed completo
marcis marcis 2 minutos hace
Lover this

Did you know besides the great Greek restaurants and great bakeries in Astoria Queens NYC there is a Good Maltese area. In Greek Astoria Qyeens

With a good Maltese club just near the Whitestone bridge Mm
RDAR
pos_stock_hoarder pos_stock_hoarder 3 minutos hace
Yes, but not how he caught him. Bait in the cage I suppose?
Soapboxmom Soapboxmom 3 minutos hace
$0.000000600

Overview
Token logo
AURI INC

AURI
$0.0000006600
Market Cap $4,860

Liquidity $1,220

Holders 83

Total Supply 10 B

Circulating Supply 8.1 B

That art and th
AURI
Edward Edward 5 minutos hace
LOL.

I have to agree, I'm thinking they extended the portal purchase for a reason!

VXIT didn't extend anything, the MFG. did.

The only reason, the Mfg, of the portals eliminated the deadline is they themselves do not have any cash to release the $10k back
VXIT
pos_stock_hoarder pos_stock_hoarder 6 minutos hace
Biden Renews Technology-Sharing Treaty with China

First, he can't even fathom the writing on a box of Capn Crunch much less review anything.

More importantly, he and his flying monkey brigade (think Wizard of Oz) are owned by China. Lock stock and barrel.
Implanting Implanting 7 minutos hace
Yes, I find it more than coincidental that Dan keeps talking about the Osisko/Goldfields deal AND that even in this last interview he just happens to mention how much money the deal was for.

Is Osisko's Windfall property comparable to Springpole? I think Windfall may have been a bett
FFMGF
al44 al44 7 minutos hace
RINOs take notice-

https://media.gettr.com/group4/getter/2024/12/22/00/4e43df68-57d2-e8d6-2bd6-f4e6ffdb701d/075551454b47a287af56769c10a9a16e_768x0.jpg
mrfence mrfence 8 minutos hace
Our $FMCC~ $FNMA~ House
https://media.gettyimages.com/id/81929022/photo/a-view-of-fannie-mae-headquarters-is-seen-on-july-14-2008-in-washington-dc-shares-in-fannie-mae.jpg?s=612x612&w=0&k=20&c=pLp_iizpiI54bHNKnTlWnuTPuJKw1-BnDm4gCvAfrEQ=
[yt]aunVlekXjkE?si=AboikGW1qLTNq8pV[/yt]
FMCC FNMA
Zilla Zilla 8 minutos hace
IMO...The chart looks very interesting...Could keep climbing but...black lines climbing up decreasing (5/4/3) and never more than 2 red lines since November...Also Fridays black line is lower than the day before's red line which is looking like a head of something..Hummmm...Maybe not, as a chart is
SOUN
dexprs dexprs 8 minutos hace
Steve Sears at Barron's has a good weekly article on Options trading, which are interesting and also actionable.
It is under: Strike Price heading.
lager lager 9 minutos hace
Exactly the same unrelated nonsensical garbage that got them TOS reported. 
MGON
jwood9207 jwood9207 9 minutos hace
Thank you for this. The only reason I suffer the eternal, unending BS on this board is for the occasional gem like this.
FNMA
BakedLangostino BakedLangostino 10 minutos hace
And yet despite the "outlandish" compensation packages, we're still at the post-submission stage with fewer than 90 million shares outstanding, zero debt, and $100mm or so in the bank. Sounds like Dr. M has been a fairly decent steward of investors' funds compared to, I don't know, Remy over at Cass
AVXL
primecomm primecomm 10 minutos hace
Going to add some more cheapies pre-market tomorrow.
TNXP
dexprs dexprs 10 minutos hace
I use the one on Chrome and I hardly see any ads. The one Elroy sent you a link to.
Investor082 Investor082 11 minutos hace
Haha, agreed!
NWBO
Boiler_Master Boiler_Master 11 minutos hace
Should be a great year. I've looked through a few previous quarterly reports and their gross profit (revenue minus cost of revenue) was around 32% one quarter and 41% in another. They just didn't have alot of sales back then. With all these new distribution deals I'm hoping to see in the neighborhoo
EDXC
Investor082 Investor082 11 minutos hace
Don’t sell a single share, LP will thank you and include you in the hall of bag holders! ;) Some of us will get a bit more for our shares when there are less number of folks selling. So we will thank you as well.
NWBO
al44 al44 11 minutos hace
Absolutely, any normal person would-

https://media.gettr.com/group8/getter/2024/12/22/03/f3b958e5-d16f-1f7b-5a08-712c5ae83f9b/efa596faf3f0c9c6182192f84cc8d32c_768x0.jpg
manibiotech manibiotech 12 minutos hace
Using rapid and NWBO in same sentence is irresponsible at the very least 
NWBO
Guzzi62 Guzzi62 12 minutos hace
I suggest you go see a psychiatrist, you seem to have mental problems.
AVXL
al44 al44 13 minutos hace
This is terrorism, death penalty appropriate-

https://gettr.com/post/p3f6ggfb40d
PMS Witch PMS Witch 14 minutos hace
The only thing more expensive than deporting illegals… is not deporting them.

From a Daniel Greenfield article.

https://www.danielgreenfield.org/2024/12/mass-deportations-would-save-americans.html Link to article

Cheers, PW.
Bull_Dolphin Bull_Dolphin 14 minutos hace
They show the wildlife guy releasing him at the very end.

Su Consulta Reciente

NASDAQ
XOMAO
XOMA Royalty
DGFX
ONGBTC
Ontology Gas
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados